Reliability and validity of the greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Kontodimopoulos, Nick ^a   Samartzis, Alexandros ^a,b   Papadopoulos, Angelos A ^a   Niakas, Dimitris ^a  

^a HELLENIC OPEN UNIVERSITY   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; COGNITION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DEMOGRAPHY; GOLD STANDARD; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; MULTICENTER STUDY; MULTIPLE MYELOMA; PSYCHOMETRY; QLQ C30 RATING SCALE; QLQ MY20 RATING SCALE; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SHORT FORM 36; VALIDITY; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; VALIDATION STUDY;

HUMANS; MULTIPLE MYELOMA; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 84866148839     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/842867     Document Type: Article

References (44)

1. Raab M. S., Podar K., Breitkreutz I., Richardson P. G., Anderson K. C., Multiple myeloma. The Lancet 2009 374 9686 324 339 2-s2.0-67650726486 10.1016/S0140-6736(09)60221-X
2. Fritschi L., Siemiatycki J., Lymphoma, myeloma and occupation: results of a case-control study. International Journal of Cancer 1996 67 4 498 503 10.1002/(SICI)1097-0215(19960807)67:4498::AID-IJC6>3.0.CO;2-N (Pubitemid 26274105)
3. Koessel S. L., Theis M. K., Vaughan T. L., Koepsell T. D., Weiss N. S., Greenberg R. S., Swanson G. M., Socioeconomic status and the incidence of multiple myeloma. Epidemiology 1996 7 1 4 8 2-s2.0-0030021198 (Pubitemid 26003838)
4. Sirohi B., Powles R., Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. European Journal of Cancer 2006 42 11 1671 1683 2-s2.0-33746326784 10.1016/j.ejca.2006.01.065 (Pubitemid 44118778)
5. Gulbrandsen N., Hjermstad M. J., Wisloff F., Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. European Journal of Haematology 2004 72 3 172 180 2-s2.0-1342322717 10.1046/j.0902-4441.2003.00195.x (Pubitemid 38250794)
6. Bottomley A., Quinten C., Coens C., Martinelli F., Mauer M., Maringwa J., Cleeland C. S., Flechtner H., Gotay C., Greimel E., King M., Osoba D., Taphoorn M. J. B., Reeve B. B., Ringash J., Schmucker-Von Koch J., Weis J., Making better use of existing cancer data: patient reported outcomes and behavioural evidence: a new international initiative. European Journal of Cancer Care 2009 18 2 105 107 2-s2.0-61349159417 10.1111/j.1365-2354.2009.01092.x
7. Efficace F., Kemmler G., Vignetti M., Mandelli F., Molica S., Holzner B., Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trialsa systematic review to evaluate the added value in supporting clinical decision making. European Journal of Cancer 2008 44 11 1497 1506 2-s2.0-46049099564 10.1016/j.ejca.2008.03.017
8. Kvam A. K., Fayers P., Hjermstad M., Gulbrandsen N., Wisloff F., Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations. European Journal of Haematology 2009 83 4 279 289 2-s2.0-70349126639 10.1111/j.1600-0609.2009.01303.x
9. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., De Haes J. C. J. M., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P. B., Schraub S., Sneeuw K., Sullivan M., Takeda F., The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute 1993 85 5 365 376 2-s2.0-0027417437 (Pubitemid 23073154)
10. Wisloff F., Eika S., Hippe E., Hjorth M., Holmberg E., Kaasa S., Palva I., Westin J., Measurement of health-related quality of life in multiple myeloma. British Journal of Haematology 1996 92 3 604 613 2-s2.0-0029869758 (Pubitemid 26076761)
11. Stead M. L., Brown J. M., Velikova G., Kaasa S., Wisloff F., Child J. A., Hippe E., Hjorth M., Sezer O., Selby P., Development of an EORTC questionnaire module to be used in health- related quality-of-life assessment for patients with multiple myeloma. British Journal of Haematology 1999 104 3 605 611 2-s2.0-0032988090 (Pubitemid 29119288)
12. Cocks K., Cohen D., Wisloff F., Sezer O., Lee S., Hippe E., Gimsing P., Turesson I., Hajek R., Smith A., Graham L., Phillips A., Stead M., Velikova G., Brown J., An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer 2007 43 11 1670 1678 2-s2.0-34447266200 10.1016/j.ejca.2007.04.022 (Pubitemid 47042371)
13. Dewolf L., Koller M., Velikova G., EORTC Quality of Life Group Translation Procedure 2009 3rd Brussels, Belgium EORTC
14. Mystakidou K., Tsilika E., Parpa E., Kalaidopoulou O., Smyrniotis V., Vlahos L., The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) In terminally ill cancer patients under palliative care: validity and reliability in a hellenic sample. International Journal of Cancer 2001 94 1 135 139 2-s2.0-0035480046 10.1002/ijc.1439 (Pubitemid 32801762)
15. Koukouli S., Stamou A., Alegakis A., Georgoulias V., Samonis G., Psychometric properties of the QLQ-C30 (version 3.0) in a sample of ambulatory Cretan cancer patients. European Journal of Cancer Care 2009 18 5 447 456 2-s2.0-69149104292 10.1111/j.1365-2354.2008.00934.x
16. Kontodimopoulos N., Ntinoulis K., Niakas D., Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. European Journal of Cancer Care 2011 20 3 354 361 2-s2.0-79952769865 10.1111/j.1365-2354.2009.01170.x
17. Fayers P., Aaronson N., Bjordal K., Groenvold M., Curran D., Bottomley A., EORTC QLQ-C30 Scoring Manual EORTC Quality of Life Group 2001 3rd EORTC Brussels, Belgium
18. Pappa E., Kontodimopoulos N., Niakas D., Validating and norming of the Greek SF-36 Health Survey. Quality of Life Research 2005 14 5 1433 1438 2-s2.0-21244440723 10.1007/s11136-004-6014-y (Pubitemid 40895766)
19. Anagnostopoulos F., Niakas D., Pappa E., Construct validation of the Greek SF-36 Health Survey. Quality of Life Research 2005 14 8 1959 1965 2-s2.0-24644473740 10.1007/s11136-005-3866-8 (Pubitemid 41279619)
20. Ware J. E., Sherbourne C. D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992 30 6 473 483 2-s2.0-0026877917
21. Dimopoulos M., Spencer A., Attal M., Prince H. M., Harousseau J. L., Dmoszynska A., San Miguel J., Hellmann A., Facon T., Foà R., Corso A., Masliak Z., Olesnyckyj M., Yu Z., Patin J., Zeldis J. B., Knight R. D., Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. New England Journal of Medicine 2007 357 21 2123 2132 2-s2.0-36349023319 10.1056/NEJMoa070594 (Pubitemid 350146107)
22. Dimopoulos M., Terpos E., Comenzo R. L., Tosi P., Beksac M., Sezer O., Siegel D., Lokhorst H., Kumar S., Rajkumar S. V., Niesvizky R., Moulopoulos L. A., Durie B. G., International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia 2009 23 9 1545 1556 2-s2.0-70349303765
23. Palumbo A., Sezer O., Kyle R., Miguel J. S., Orlowski R. Z., Moreau P., Niesvizky R., Morgan G., Comenzo R., Sonneveld P., Kumar S., Hajek R., Giralt S., Bringhen S., Anderson K. C., Richardson P. G., Cavo M., Davies F., Bladé J., Einsele H., Dimopoulos M. A., Spencer A., Dispenzieri A., Reiman T., Shimizu K., Lee J. H., Attal M., Boccadoro M., Mateos M., Chen W., Ludwig H., Joshua D., Chim J., Hungria V., Turesson I., Durie B. G. M., Lonial S., International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia 2009 23 10 1716 1730 2-s2.0-70350094381 10.1038/leu.2009.122
24. Terpos E., Dimopoulos M. A., Sezer O., Roodman D., Abildgaard N., Vescio R., Tosi P., Garcia-Sanz R., Davies F., Chanan-Khan A., Palumbo A., Sonneveld P., Drake M. T., Harousseau J. L., Anderson K. C., Durie B. G. M., The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group. Leukemia 2010 24 10 1700 1712 2-s2.0-77957991625 10.1038/leu.2010.173
25. Wan-Po A. L., Dictionary of Evidence-Based Medicine 1998 Abingdon, UK Radcliffe Medical Press
26. Nunnaly J. C., Bernstein I. R., Psychometric Theory 1994 3rd New York, NY, USA McGraw-Hill
27. Ware J. E., Gandek B., Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. Journal of Clinical Epidemiology 1998 51 11 945 952 2-s2.0-0032211560 10.1016/S0895-4356(98)00085-7 (Pubitemid 28527149)
28. Apolone G., Filiberti A., Cifani S., Ruggiata R., Mosconi P., Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Annals of Oncology 1998 9 5 549 557 2-s2.0-0031813619 10.1023/A:1008264412398 (Pubitemid 28270644)
29. Luo N., Fones C. S. L., Lim S. E., Xie F., Thumboo J., Li S. C., The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): validation of English version in Singapore. Quality of Life Research 2005 14 4 1181 1186 2-s2.0-18844371988 10.1007/s11136-004-4782-z (Pubitemid 40685240)
30. Cohen J., A power primer. Psychological Bulletin 1992 112 1 155 159 2-s2.0-11944272254
31. Jayasekara H., Rajapaksa L. C., Brandberg Y., Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23. Quality of Life Research 2008 17 6 927 932 2-s2.0-48449101858 10.1007/s11136-008-9359-9
32. Kontodimopoulos N., Niakas D., Determining the basic psychometric properties of the Greek KDQOL-SF. Quality of Life Research 2005 14 8 1967 1975 2-s2.0-24644469247 10.1007/s11136-005-3868-6 (Pubitemid 41279620)
33. Hjermstad M. J., Fayers P. M., Bjordal K., Kaasa S., Health-related quality of life in the general Norwegian population assessed by the European organization for research and treatment of cancer core quality-of-life questionnaire: the QLQ=C30 (+3). Journal of Clinical Oncology 1998 16 3 1188 1196 2-s2.0-0031910492 (Pubitemid 28108757)
34. Greipp P. R., Miguel J. S., Dune B. G. M., Crowley J. J., Barlogie B., Bladé J., Boccadoro M., Child J. A., Harousseau J.-L., Kyle R. A., Lahuerta J. J., Ludwig H., Morgan G., Powles R., Shimizu K., Shustik C., Sonneveld P., Tosi P., Turesson I., Westin J., International staging system for multiple myeloma. Journal of Clinical Oncology 2005 23 15 3412 3420 10.1200/JCO.2005.04.242
35. Wisloff F., Hjorth M., Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. British Journal of Haematology 1997 97 1 29 37 2-s2.0-0030935165 (Pubitemid 27179561)
36. Sirohi B., Powles R., Lawrence D., Treleaven J., Kulkarni S., Leary A., Rudin C., Horton C., Morgan G., An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon- α 2b in patients with multiple myeloma maintained on a steady dose of interferon- α 2b. Annals of Oncology 2007 18 8 1388 1394 2-s2.0-34548150428 10.1093/annonc/mdm180 (Pubitemid 47305014)
37. European Organization for Research and Treatment of Cancer (EORTC). 2011
38. Scott N. W., Fayers P. M., Aaronson N. K., EORTC QLQ-C30 Reference Values 2008 Brussels, Belgium EORTC
39. Chie W. C., Chang K. J., Huang C. S., Kuo W. H., Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psycho-Oncology 2003 12 7 729 735 2-s2.0-0141921517 10.1002/pon.727 (Pubitemid 37236025)
40. Wan C., Tang X., Tu X. M., Feng C., Messing S., Meng Q., Zhang X., Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. Breast Cancer Research and Treatment 2007 105 2 187 193 2-s2.0-34548462906 10.1007/s10549-006-9443-1 (Pubitemid 47366881)
41. Awad M. A., Denic S., El Taji H., Validation of the European organization for research and treatment of cancer quality of life questionnaires for Arabic-speaking populations. Annals of the New York Academy of Sciences 2008 1138 146 154 2-s2.0-53149116322 10.1196/annals.1414.021
42. Yun Y. H., Bae S. H., Kang I. O., Shin K. H., Lee R., Kwon S. I., Park Y. S., Lee E. S., Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer- Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Supportive Care in Cancer 2004 12 6 441 445 2-s2.0-2942741333 10.1007/s00520-004-0632-3 (Pubitemid 38797100)
43. Kuenstner S., Langelotz C., Budach V., Possinger K., Krause B., Sezer O., The comparability of quality of life scores: a multitrait multimethod analysis of the EORTC QLQ-C30, SF-36 and FLIC questionnaires. European Journal of Cancer 2002 38 3 339 348 2-s2.0-0036164596 10.1016/S0959-8049(01)00369-0 (Pubitemid 34121961)
44. Montazeri A., Harirchi I., Vahdani M., Khaleghi F., Jarvandi S., Ebrahimi M., Haji-Mahmoodi M., The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Quality of Life Research 2000 9 2 177 184 2-s2.0-0033856945 10.1023/A:1008918310251